Royalty Pharma Plc is a leading pharmaceutical company based in the United States. With an ESG score of 26.7, the company is at a medium risk level. Specializing in buying biopharmaceutical royalties, Royalty Pharma holds a diverse portfolio of royalties that generate income based on the sales of various biopharma products. They receive royalties from over 35 commercial products, including big names like AbbVie, Johnson & Johnson, Biogen, and Vertex.